Needham & Company LLC Forecasts RYTM FY2029 Earnings
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) – Equities researchers at Needham & Company LLC issued their FY2029 earnings per share estimates for Rhythm Pharmaceuticals in a report issued on Thursday, February 6th. Needham & Company LLC analyst J. Stringer anticipates that the company will post earnings of $6.55 per share for the year. Needham […]
![Needham & Company LLC Forecasts RYTM FY2029 Earnings](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/rhythm-pharmaceuticals-inc-logo-1200x675.jpg?v=20221129165512&w=240&h=240&zc=2)